Induced neural stem/precursor cells for fundamental studies and potential application in neurodegenerative diseases
Ting Shen1, Jiali Pu1, Tingting Zheng1
1Department of Neurology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, China.
Abstract:
Recent research has shown that defined sets of exogenous factors are sufficient to convert rodent and human somatic cells directly into induced neural stem cells or neural precursor cells (iNSCs/iNPCs). The process of transdifferentiation bypasses the step of a pluripotent state and reduces the risk of tumorigenesis and genetic instability while retaining the self-renewing capacity. This iNSC/iNPC technology has fueled much excitement in regenerative medicine, as these cells can be differentiated into target cells for re placement therapy for neurodegenerative diseases. Patients' somatic cell-derived iNSCs/iNPCs have also been proposed to serve as disease models with potential value in both fundamental studies and clinical applications. This review focuses on the mechanisms, techniques, and app lications of iNSCs/iNPCs from a series of related studies, as well as further efforts in designing novel strategies using iNSC/iNPC technology and its potential applications in neurodegenerative diseases.
Insights
Defined factors convert somatic cells into induced neural stem cells (iNSCs/iNPCs) via transdifferentiation. This bypasses pluripotency, reducing risks and offering potential for regenerative medicine and disease modeling in neurodegenerative conditions.
Area of Science:
- Biotechnology
- Stem Cell Biology
- Neuroscience
Background:
- Somatic cells can be directly converted into induced neural stem cells or neural precursor cells (iNSCs/iNPCs) using specific exogenous factors.
- This transdifferentiation process circumvents a pluripotent stage, mitigating risks of tumorigenesis and genetic instability while preserving self-renewal capacity.
Purpose of the Study:
- To review the mechanisms, techniques, and applications of iNSC/iNPC technology.
- To explore novel strategies and potential applications of iNSC/iNPCs in treating neurodegenerative diseases.
Main Methods:
- Review of existing literature on iNSC/iNPC generation and application.
- Analysis of transdifferentiation mechanisms bypassing pluripotency.
- Examination of therapeutic and disease modeling potential.
Main Results:
- Exogenous factors are sufficient for direct somatic cell conversion to iNSCs/iNPCs.
- Transdifferentiation offers a safer alternative to pluripotent stem cells for regenerative applications.
- iNSC/iNPCs show promise for neurodegenerative disease modeling and potential cell replacement therapies.
Conclusions:
- iNSC/iNPC technology represents a significant advancement in regenerative medicine for neurodegenerative disorders.
- Direct reprogramming bypasses pluripotency, enhancing safety and therapeutic potential.
- Further research into novel strategies can unlock the full clinical utility of iNSC/iNPCs.
Related Concept Videos
Induced Pluripotent Stem Cells
EPS and iPS Cells in Disease Research
iPS Cell Differentiation


